IP Library › Granted Patent US 12,274,884
Granted Patent B2
US 12,274,884 · App. 17/955,478 · Granted Apr 15, 2025

Automatic selection of parameters of an exposure mode of an implantable medical device

Inventors: Michael L. Ellingson (St. Louis Park, MN); Hyun J. Yoon (Vadnais Heights, MN)
Assignee: Medtronic, Inc.
A61N1/3718A61N1/37254A61N1/3688
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,884
App. No.
17/955,478
Granted
Apr 15, 2025
Kind
B2
Abstract

An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.

Claims (90)

1. A method comprising:

automatically determining, with a first device, one or more parameters of an exposure operating mode based on at least one of stored information related to sensed physiological events and/or stored information related to therapy provided over a predetermined period time by:

analyzing a PAV interval measured during the predetermined period of time, wherein the stored information includes the PAV interval measured during the predetermined period of time; and

selecting a PAV interval as one of the parameters to be implemented during the exposure operating mode based on the analysis;

after automatically determining the one or more parameters of the exposure operating mode, storing the automatically determined parameters of the exposure operating mode in a memory;

switching operation of an implantable medical device from parameters of a current operating mode to the one or more automatically determined parameters of the exposure operating mode; and

delivering therapy by the implantable medical device implementing the one or more automatically determined parameters of the exposure operating mode.

2. The method of claim 1 , wherein analyzing the PAV interval includes analyzing an average PAV interval measured during the predetermined period of time, the stored information includes the average PAV interval measured during the predetermined period of time, and selecting the PAV interval to be implemented during the exposure mode based on the analysis includes selecting based on the analysis of the average PAV interval measured during the predetermined period of time.

3. The method of claim 2 , wherein selecting the PAV interval to be implemented during the exposure mode based on the analysis further comprises:

selecting a first fixed PAV interval when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a first PAV interval threshold;

selecting the average PAV interval measured during the predetermined period of time when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a second PAV interval threshold, and less than the first PAV interval threshold; and

selecting a second fixed PAV interval when the average PAV interval measured during the predetermined period of time is less than the second PAV interval threshold.

4. The method of claim 3 , wherein the first fixed PAV interval is approximately one hundred and ten milliseconds, the first PAV interval threshold is approximately one hundred and ten milliseconds, the second fixed PAV interval is approximately fifty milliseconds, and the second PAV interval threshold is approximately fifty milliseconds.

5. The method of claim 1 , wherein automatically determining the one or more parameters of the exposure operating mode further comprises:

analyzing a maximum pacing amplitude measured during the predetermined period of time, wherein the stored information includes the maximum pacing amplitude measured during the predetermined period of time;

selecting a pacing amplitude to be delivered during the exposure operating mode as a fixed pacing amplitude when the maximum pacing amplitude measured during the predetermined period of time is less than a maximum pacing amplitude threshold; and

selecting the pacing amplitude to be delivered during the exposure operating mode as the maximum pacing amplitude measured during the predetermined period of time when the maximum pacing amplitude measured during the predetermined period of time is approximately equal to or greater than the maximum pacing amplitude threshold measured during the predetermined period of time,

wherein the fixed pacing amplitude is approximately five volts, and the maximum pacing amplitude threshold is approximately five volts.

6. The method of claim 1 , wherein automatically determining the one or more parameters of the exposure operating mode further comprises:

analyzing a maximum pacing pulse width measured during the predetermined period of time, wherein the stored information includes the maximum pacing pulse width measured during the predetermined period of time;

selecting a pacing pulse width to be delivered during the exposure operating mode as a fixed pacing pulse width when the maximum pacing width measured during the predetermined period of time is less than a maximum pacing pulse width threshold; and

selecting the pacing pulse width to be delivered during the exposure operating mode

as the maximum pulse width measured during the predetermined period of time when the maximum pacing pulse width is approximately equal to or greater than the maximum pacing pulse width threshold,

wherein the fixed pacing pulse width is approximately one millisecond, and the maximum pacing pulse width threshold is approximately one millisecond.

7. The method of claim 1 , wherein the first device is the implantable medical device.

8. An implantable medical device comprising:

a memory; and

a processor configured for:

automatically determining one or more parameters of an exposure operating mode based on at least one of stored information related to sensed physiological events and/or stored information related to therapy provided over a predetermined period time by:

analyzing a PAV interval measured during the predetermined period of time, wherein the stored information includes the PAV interval measured during the predetermined period of time; and

selecting a PAV interval to be implemented during the exposure operating mode based on the analysis;

after automatically determining the one or more parameters of the exposure operating mode, storing the automatically determined parameters of the exposure operating mode in the memory;

switching operation of the implantable medical device from parameters of a current operating mode to the one or more automatically determined parameters of the exposure operating mode; and

delivering therapy by implementing the one or more automatically determined parameters of the exposure operating mode.

9. The device of claim 8 , wherein analyzing the PAV interval includes analyzing an average PAV interval measured during the predetermined period of time, the stored information includes the average PAV interval measured during the predetermined period of time, and the processor is further configured for:

selecting the PAV interval to be implemented during the exposure operating mode as a first fixed PAV interval when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a first PAV interval threshold;

selecting the PAV interval to be implemented during the exposure operating mode as the average PAV interval measured during the predetermined period of time when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a second PAV interval threshold, and less than the first PAV interval threshold; and

selecting the PAV interval to be implemented during the exposure operating mode as a second fixed PAV interval when the average PAV interval measured during the predetermined period of time is less than the second PAV interval threshold,

wherein the first fixed PAV interval is approximately one hundred and ten milliseconds, the first PAV interval threshold is approximately one hundred and ten milliseconds, the second fixed PAV interval is approximately fifty milliseconds, and the second PAV interval threshold is approximately fifty milliseconds.

10. The device of claim 8 , further configured for:

analyzing a maximum pacing amplitude and a maximum pacing pulse width measured during the predetermined period of time, wherein the stored information includes the maximum pacing amplitude and the maximum pacing pulse width measured during the predetermined period of time;

selecting a pacing amplitude to be delivered during the exposure operating mode as a fixed pacing amplitude when the maximum pacing amplitude measured during the predetermined period of time is less than a maximum pacing amplitude threshold;

selecting the pacing amplitude to be delivered during the exposure operating mode as the maximum pacing amplitude measured during the predetermined period of time when the maximum pacing amplitude measured during the predetermined period of time is approximately equal to or greater than the maximum pacing amplitude threshold measured during the predetermined period of time;

selecting a pacing pulse width to be delivered during the exposure operating mode as a fixed pacing pulse width when the maximum pacing width measured during the predetermined period of time is less than a maximum pacing pulse width threshold; and

selecting the pacing pulse width to be delivered during the exposure operating mode as the maximum pulse width measured during the predetermined period of time when maximum pacing pulse width is approximately equal to or greater than the maximum pacing pulse width threshold,

wherein the fixed pacing amplitude is approximately five volts, the maximum pacing amplitude threshold is approximately five volts, the fixed pacing pulse width is approximately one millisecond, and the maximum pacing pulse width threshold is approximately one millisecond.

11. A method comprising:

automatically determining, with a first device, one or more parameters of an exposure operating mode based on at least one of stored information related to sensed physiological events and/or stored information related to therapy provided over a predetermined period time by:

analyzing at least one of a maximum pacing amplitude and/or a maximum pacing pulse width measured during the predetermined period of time, wherein the stored information includes the maximum pacing amplitude and/or the maximum pacing pulse width measured during the predetermined period of time; and

selecting at least one of a pacing amplitude and/or pacing pulse width to be delivered during the exposure operating mode based on the analysis;

after automatically determining the one or more parameters of the exposure operating mode, storing the automatically determined parameters of the exposure operating mode in a memory;

switching operation of an implantable medical device from parameters of a current operating mode to the one or more automatically determined parameters of the exposure operating mode; and

delivering therapy by the implantable medical device implementing the one or more automatically determined parameters of the exposure operating mode.

12. The method of claim 11 , wherein selecting the pacing amplitude and/or pacing pulse width to be delivered during the exposure operating mode further comprises:

selecting the pacing amplitude as a fixed pacing amplitude when the maximum pacing amplitude measured during the predetermined period of time is less than a maximum pacing amplitude threshold; and

selecting the pacing amplitude as the maximum pacing amplitude measured during the predetermined period of time when the maximum pacing amplitude measured during the predetermined period of time is approximately equal to or greater than the maximum pacing amplitude threshold measured during the predetermined period of time.

13. The method of claim 12 , wherein the fixed pacing amplitude is approximately five volts, and the maximum pacing amplitude threshold is approximately five volts.

14. The method of claim 11 , wherein automatically determining the one or more parameters of the exposure operating mode further comprises:

analyzing an average PAV interval measured during the predetermined period of time, wherein the stored information includes the average PAV interval measured during the predetermined period of time;

selecting a PAV interval to be implemented during the exposure operating mode as a first fixed PAV interval when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a first PAV interval threshold;

selecting the PAV interval to be implemented during the exposure operating mode as the average PAV interval measured during the predetermined period of time when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a second PAV interval threshold, and less than the first PAV interval threshold; and

selecting the PAV interval to be implemented during the exposure operating mode as a second fixed PAV interval when the average PAV interval measured during the predetermined period of time is less than the second PAV interval threshold,

wherein the first fixed PAV interval is approximately one hundred and 10 milliseconds, the first PAV interval threshold is approximately one hundred and 10 milliseconds, the second fixed PAV interval is approximately fifty milliseconds, and the second PAV interval threshold is approximately fifty milliseconds.

15. The method of claim 11 , wherein selecting the pacing pulse width to be implemented during the exposure mode based on the analysis further comprises:

selecting the pacing pulse width as a fixed pacing pulse width when the maximum pacing pulse width measured during the predetermined period of time is less than a maximum pacing pulse width threshold; and

selecting the pacing pulse width as maximum pulse width measured during the predetermined period of time when maximum pacing pulse width is approximately equal to or greater than the maximum pacing pulse width threshold.

16. The method of claim 15 , wherein the fixed pacing pulse width is approximately one millisecond, and the maximum pacing pulse width threshold is approximately one millisecond.

17. An implantable medical device comprising:

a memory; and

a processor configured for:

automatically determining one or more parameters of an exposure operating mode based on at least one of stored information related to sensed physiological events and/or stored information related to therapy provided over a predetermined period time by:

analyzing at least one of a maximum pacing amplitude and/or a maximum pacing pulse width measured during the predetermined period of time, wherein the stored information includes the maximum pacing amplitude and/or maximum pacing pulse width measured during the predetermined period of time; and

selecting at least one of a pacing amplitude and/or a pacing pulse width to be delivered during the exposure operating mode based on the analysis;

after automatically determining the one or more parameters of the exposure operating mode, storing the automatically determined parameters of the exposure operating mode in the memory;

switching operation of the implantable medical device from parameters of a current operating mode to the one or more automatically determined parameters of the exposure operating mode; and

delivering therapy by implementing the one or more automatically determined parameters of the exposure operating mode.

18. The device of claim 17 , wherein the processor is further configured for:

selecting the pacing amplitude to be delivered during the exposure operating mode as a fixed pacing amplitude when the maximum pacing amplitude measured during the predetermined period of time is less than a maximum pacing amplitude threshold; and

selecting the pacing amplitude to be delivered during the exposure operating mode as the maximum pacing amplitude measured during the predetermined period of time when maximum pacing amplitude measured during the predetermined period of time is approximately equal to or greater than the maximum pacing amplitude threshold measured during the predetermined period of time,

wherein the fixed pacing amplitude is approximately five volts, and the maximum pacing amplitude threshold is approximately five volts.

19. The device of claim 17 , wherein the processor is further configured for:

selecting the pacing pulse width to be delivered during the exposure operating mode as a fixed pacing pulse width when the maximum pacing pulse width measured during the predetermined period of time is less than a maximum pacing pulse width threshold; and

selecting the pacing pulse width to be delivered during the exposure operating mode as maximum pulse width measured during the predetermined period of time when maximum pacing pulse width is approximately equal to or greater than the maximum pacing pulse width threshold,

wherein the fixed pacing pulse width is approximately one millisecond, and the maximum pacing pulse width threshold is approximately one millisecond.

20. The device of claim 17 , wherein the processor is further configured for:

analyzing an average PAV interval measured during the predetermined period of time, the stored information includes the average PAV interval measured during the predetermined period of time;

selecting a PAV interval to be implemented during the exposure operating mode as a first fixed PAV interval when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a first PAV interval threshold;

selecting the PAV interval to be implemented during the exposure operating mode as the average PAV interval measured during the predetermined period of time when the average PAV interval measured during the predetermined period of time is approximately equal to or greater than a second PAV interval threshold, and less than the first PAV interval threshold; and

selecting the PAV interval to be implemented during the exposure operating mode as a second fixed PAV interval when the average PAV interval measured during the predetermined period of time is less than the second PAV interval threshold,

wherein the first fixed PAV interval is approximately one hundred and ten milliseconds, the first PAV interval threshold is approximately one hundred and ten milliseconds, the second fixed PAV interval is approximately fifty milliseconds, and the second PAV interval threshold is approximately fifty milliseconds.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: ELLINGSON, MICHAEL L.; YOON, HYUN J.
To: MEDTRONIC, INC.
Reel/Frame 061250/0193 →
Continuity (4)
Continuation 16697267 · Nov 27, 2019
Continuation 14886152 · Oct 19, 2015
Division 12569101 · Sep 29, 2009
Related Publication 20230027466A1 · Jan 26, 2023
References Cited (87)
US 5174289A · Cohen · 1992 [cited by applicant]
US 5722998A · Prutchi et al. · 1998 [cited by applicant]
US 5978710A · Prutchi et al. · 1999 [cited by applicant]
US 6937906B2 · Terry et al. · 2005 [cited by applicant]
US 7039810B1 · Nichols · 2006 [cited by applicant]
US 7050855B2 · Zeijlemaker et al. · 2006 [cited by applicant]
US 7076283B2 · Cho et al. · 2006 [cited by applicant]
US 7212863B2 · Strandberg · 2007 [cited by applicant]
US 7561915B1 · Cook et al. · 2009 [cited by applicant]
US 7623930B2 · Zeijiemaker et al. · 2009 [cited by applicant]
US 7697988B2 · Clement et al. · 2010 [cited by applicant]
US 8014867B2 · Cooke et al. · 2011 [cited by applicant]
US 8046063B2 · Betzold · 2011 [cited by applicant]
US 8121678B2 · Linder et al. · 2012 [cited by applicant]
US 8200334B1 · Min et al. · 2012 [cited by applicant]
US 8433408B2 · Ellingson et al. · 2013 [cited by applicant]
US 8437862B2 · Yoon et al. · 2013 [cited by applicant]
US 8467882B2 · Ellingson et al. · 2013 [cited by applicant]
US 8538550B2 · Stubbs et al. · 2013 [cited by applicant]
US 8554318B2 · Legay · 2013 [cited by applicant]
US 8737862B2 · Manico et al. · 2014 [cited by applicant]
US 8744578B2 · Ellingson · 2014 [cited by applicant]
US 8805496B2 · Ellingson · 2014 [cited by applicant]
US 8818506B2 · Legay · 2014 [cited by applicant]
US 8886317B2 · Cooke et al. · 2014 [cited by applicant]
US 8896462B2 · Skoldengen et al. · 2014 [cited by applicant]
US 8929995B2 · Stancer et al. · 2015 [cited by applicant]
US 9008788B2 · Jenison · 2015 [cited by applicant]
US 9095721B2 · Stancer et al. · 2015 [cited by applicant]
US 9138584B2 · Stancer et al. · 2015 [cited by applicant]
US 9174058B2 · Ellingson · 2015 [cited by examiner]
US 9272152B2 · Lalonde et al. · 2016 [cited by applicant]
US 9919158B2 · Ellingson et al. · 2018 [cited by applicant]
US 10130282B2 · Goetz et al. · 2018 [cited by applicant]
US 10130822B2 · Legay et al. · 2018 [cited by applicant]
US 10293167B2 · Yoon et al. · 2019 [cited by applicant]
US 10441798B2 · Yoon et al. · 2019 [cited by applicant]
US 10493286B2 · Ellingson · 2019 [cited by examiner]
US 10668292B2 · Pei et al. · 2020 [cited by applicant]
US 10744320B2 · Newman et al. · 2020 [cited by applicant]
US 10981010B2 · Yoon et al. · 2021 [cited by applicant]
US 11253707B2 · Yoon et al. · 2022 [cited by applicant]
US 11478647B2 · Ellingson · 2022 [cited by examiner]
US 11724111B2 · Yoon et al. · 2023 [cited by applicant]
US 11938326B2 · Yoon et al. · 2024 [cited by applicant]
US 20030144705A1 · Funke · 2003 [cited by applicant]
US 20030144706A1 · Funke · 2003 [cited by applicant]
US 20040024421A1 · Ideker et al. · 2004 [cited by applicant]
US 20040030256A1 · Lin · 2004 [cited by applicant]
US 20040254614A1 · Spinelli et al. · 2004 [cited by applicant]
US 20050096708A1 · Seim et al. · 2005 [cited by applicant]
US 20050149126A1 · Libbus · 2005 [cited by applicant]
US 20060167496A1 · Nelson et al. · 2006 [cited by applicant]
US 20060293591A1 · Wahlstrand et al. · 2006 [cited by applicant]
US 20070265662A1 · Ufford et al. · 2007 [cited by applicant]
US 20080154342A1 · Digby et al. · 2008 [cited by applicant]
US 20090157146A1 · Linder et al. · 2009 [cited by applicant]
US 20100137945A1 · Gadagkar et al. · 2010 [cited by applicant]
US 20110093046A1 · Ellingson et al. · 2011 [cited by applicant]
US 20110106204A1 · Yoon et al. · 2011 [cited by applicant]
US 20110152672A1 · Doerr et al. · 2011 [cited by applicant]
US 20110160565A1 · Stubbs et al. · 2011 [cited by applicant]
US 20110160791A1 · Ellingson et al. · 2011 [cited by applicant]
US 20110187360A1 · Maile et al. · 2011 [cited by applicant]
US 20110196450A1 · McClure et al. · 2011 [cited by applicant]
US 20120221068A1 · Ellingson · 2012 [cited by applicant]
US 20120245452A1 · Doerr et al. · 2012 [cited by applicant]
US 20120277817A1 · Ellingson et al. · 2012 [cited by applicant]
US 20130268012A1 · Sison · 2013 [cited by applicant]
US 20130289384A1 · Jenison et al. · 2013 [cited by applicant]
US 20140100624A1 · Ellingson · 2014 [cited by applicant]
US 20160015986A1 · Seeberger et al. · 2016 [cited by applicant]
US 20160151623A1 · Doerr · 2016 [cited by applicant]
US 20160151624A1 · Doerr · 2016 [cited by applicant]
US 20180140856A1 · Lindevig et al. · 2018 [cited by applicant]
US 20200230423A1 · Chen et al. · 2020 [cited by applicant]
US 20230061204A1 · Edmonson et al. · 2023 [cited by applicant]
US 20230181912A1 · Edmonson et al. · 2023 [cited by applicant]
US 20230364430A1 · Yoon et al. · 2023 [cited by applicant]
US 20240207620A1 · Yoon et al. · 2024 [cited by applicant]
CN 106110503A · 2016 [cited by applicant]
EP 1965450 · 2008 [cited by applicant]
WO 2010126935A2 · 2010 [cited by applicant]
PCTUS2010/031242 International Search Report and Written Opinion, Jul. 1, 2010. [cited by applicant]
Kloostermann, Dr. E. Martin, MRI Remote Control Study (ROCON) Remote Management of Cardiac Devices Undergoing MRI, received Jan. 26, 2016, 7 pgs. [cited by applicant]
Kloostermann, Dr. E. Martin, MRI Remote Control Study (ROCON). Remote Management of Cardiac Devices Undergoing MRI, received Mar. 3, 2016, 30 pgs. [cited by applicant]
Kloostermann, Dr. E. Martin,, “Novel MRI Safe Mode Selection Algorithm Standardized Real-Time Solutions for a Varialbe Time-Dependent Problem”, J. Clin Exp. Cardiology, Dec. 11-12, 2017, 22nd World Cardiology Conference. [cited by applicant]